Ajay Juneja

Ajay Juneja

Active Director Director DIN 03204109
DIN 03204109 First appointment Oct 2010 Primary industry Pharma
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 5 active board seats
Past companies 1 historical roles
Total affiliations 6 Since Oct 2010
Shareholding value β€’β€’β€’β€’ Premium profile

About Ajay Juneja

Data last updated:

Ajay Juneja is a Director at Elis Pharmaceuticals (India) Private Limited (since 2014), Designated Partner at Azpara Realty Llp (since 2024) and Designated Partner at Azpara's Tapovan Llp (since 2024), and holds 2 more current directorships. The companies operate in Pharma. The largest current company by reported revenue is Elis Pharmaceuticals (India) Private Limited at ₹3.87 Cr (FY 2024). Earlier, Ajay Juneja was a Whole-Time Director at United Pharmatech (India) Private Limited (2010–2014).

DIN 03204109
Primary Designation Director
Industry Pharma
First Appointment 25 Oct 2010
Oldest Company Age 20 yrs
Largest company Elis Pharmaceuticals (India) Private Limited Β· ₹3.87 Cr (FY 2024)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director01 Mar 20142006₹3.87 Cr (FY 2024)Active
Designated Partner18 Jun 20242024Active
Designated Partner11 Jun 20242024Active
Designated Partner24 May 20242024Active
Designated Partner28 Nov 20152015Active

Previous companies

CompanyDesignationAppointmentFoundedRevenueStatus
Whole-Time Director25 Oct 20102008₹15 Lakh (FY 2024)Active

Explore Director's current and past company associations Uncover their professional journey today!

Board colleagues of Ajay Juneja

NameDINCompanyDesignation
Sapna Kulwant Kaushik08619329Elis Pharmaceuticals (India) Private LimitedDirector
Gaurav Pathak07766121Azpara Realty Llp , Azpara's Tapovan Llp and 1 moreDesignated Partner
Kartikeya Singh Rawat10663525Azpara Realty Llp , Azpara's Tapovan LlpDesignated Partner
Manish Upadhyay10405475Azpara Realty Llp , Azpara's Tapovan Llp and 1 moreDesignated Partner
Naveen Somani01206179Azpara Realty LlpDesignated Partner
Pawan Garg01461568Azpara Realty LlpDesignated Partner
Vikas Sehgal10663524Azpara Realty Llp , Azpara's Tapovan LlpDesignated Partner
Dewashish Pathak07314267Lembos Pharmaceuticals LlpDesignated Partner
Dilip Kumar07314240Lembos Pharmaceuticals LlpDesignated Partner

Directorship timeline

Open interactive timeline →
Elis Pharmaceuticals (India) Private Limited
Lembos Pharmaceuticals Llp
Azpara Realty Llp
Azpara's Tapovan Llp
Premium access

Shareholding and investment profile for Ajay Juneja

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Ajay Juneja

Ajay Juneja currently holds 5 directorships: Elis Pharmaceuticals (India) Private Limited (Director, since 01 Mar 2014, revenue β‚Ή3.87 Cr (FY 2024)); Azpara Realty Llp (Designated Partner, since 18 Jun 2024); Azpara's Tapovan Llp (Designated Partner, since 11 Jun 2024); Azpara Infra Projects Llp (Designated Partner, since 24 May 2024); Lembos Pharmaceuticals Llp (Designated Partner, since 28 Nov 2015).

Ajay Juneja was first appointed on 25 Oct 2010 as Whole-Time Director at United Pharmatech (India) Private Limited. The most recent appointment on record is 18 Jun 2024 at Azpara Realty Llp.

Ajay Juneja held 1 earlier board appointment: United Pharmatech (India) Private Limited (Whole-Time Director, 25 Oct 2010 to 10 Mar 2014).

The current boards of Ajay Juneja's companies include Sapna Kulwant Kaushik (Elis Pharmaceuticals (India) Private Limited), Gaurav Pathak (Azpara Realty Llp), Kartikeya Singh Rawat (Azpara Realty Llp), Manish Upadhyay (Azpara Realty Llp), Naveen Somani (Azpara Realty Llp), Pawan Garg (Azpara Realty Llp), among others.

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available